WHO: Developing Countries Need Smart IP Systems For Local Medicines Production 25/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization has released a report on the role of intellectual property in local production of medicines in developing countries. According to the report, the way countries design their intellectual property system is key in the development of local innovation and production. However, health outcomes will depend on the accessibility and affordability of good-quality essential medicines.
Biotherapeutic Medicines, A New Frontier, Face Regulatory Issues 24/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Biotherapeutic medicines, engineered by living organisms, have opened a promising path to treat major diseases. Near copies of these medicines, called biosimilars, are slowly coming to market, as the originator products become free of intellectual property rights or data protection. However, some regulatory issues are left to be addressed, in particular in developing countries, according to the pharmaceutical industry and the World Health Organization. For patients, information on those products and their affordability are key, said a patient group representative.
Leading US TV Operators In IP Clash With Russian TV Channels 24/03/2016 by Eugene Gerden for Intellectual Property Watch Leave a Comment Leading Russian television channels, among which are First Channel, STS, Ren TV, TNT the Comedy, Nostalgia and some others, have filed a class action lawsuit related to intellectual property rights in a New York court against their US repeaters, including Infomir, Panorama TV, Goodzone TV.
Geographical Indications In The TTIP: Faites Vos Jeux 23/03/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment Ever heard of Törkölypálinka? It is a Hungarian grape marc spirit and one of approximately 200 geographical origins listed by the European Commission negotiators of the Transatlantic Trade and Investment Partnership (TTIP). In their newly published proposals, the EU negotiators laid out their ideas on GI protection in the deal, and point to an earlier EU-US agreement with regard to GI protection of wines and spirits. But they also acknowledge the need for considerable bridging between the two systems. GI protection is expected to be one of the highly controversial issues in the “end game” of TTIP.
South Africa: New Prominent Pro-IP Academic Comes Out Against Government 23/03/2016 by Intellectual Property Watch 2 Comments The new Anton Mostert Chair of Intellectual Property Law at the University of Stellenbosch in South Africa, Professor Sadulla Karjiker, has pointed a finger at the country’s Department of Trade and Industry (DTI) for being “unresponsive” to stakeholders offering their input into proposed IP legislation.
Special Report: India Rocked By Report Of Secret Assurance To US Industry On IP 22/03/2016 by Patralekha Chatterjee for Intellectual Property Watch 2 Comments That the Indian government has been under pressure from the United States to change its patent regime is no secret among those who follow the public discourse on intellectual property rights. Now, a new controversy about India’s alleged private assurance to the US-India Business Council (USIBC) and other lobby groups that it would not invoke compulsory licensing for commercial purposes seeks to add fuel to fiery speculation about a shift in India’s policy on IPR.
African Tech Start-Ups Face Many Challenges 21/03/2016 by Munyaradzi Makoni for Intellectual Property Watch 1 Comment DAKAR, Senegal – Rachel Sibande won accolades when she started Malawi’s first ever technology start-up mHub in 2013.
UN High-Level Panel: Ideas For Change To Global Health And IP System Proliferate 19/03/2016 by William New and Catherine Saez, Intellectual Property Watch 3 Comments Public health advocates, academics, patients, governments and others this week presented further ideas to the United Nations Secretary-General’s High-Level Panel on Access to Medicines on ways to break the longstanding pattern of expensive medical products around the world as a way to pay for research and development.
WTO: Nepal, Tanzania, Ukraine Accept Health Amendment To TRIPS Agreement 18/03/2016 by Intellectual Property Watch 1 Comment The World Trade Organization said today that momentum continues to build among member states to accept a public health amendment to the WTO intellectual property rights agreement, as three more countries adopted it in the past week.
Asian Voices On Access to Medicines: Scrap TRIPS, Voluntary Licences Not Working, FTA Threats 18/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments Speakers from Asian civil society provided recommendations to the public hearing of the United Nations Secretary General’s High-Level Panel on Access to Medicines held yesterday. They underlined the unaffordability of medicines in their countries, the inefficiency of current mechanisms such as voluntary licensing, and the pressure applied by pharmaceutical companies and the United States and Europe to prevent the use of compulsory licences. One speaker warned against the expert advice given by the World Intellectual Property Organization to least-developed countries, while others pointed to stringent intellectual property measures in free-trade agreements.